bethwarrennutrition.com
FDA grants Psilocybin breakthrough therapy designation for major depression again
The U.S Food and Drug Administration designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of the major depressive disorder ( MDD) for the second year...